Thromboelastography Market to Flourish due to Increasing Target Disease Prevalence
Thromboelastography Market The Thromboelastography Market is estimated to be valued at US$ 604.07 Mn in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Thromboelastography (TEG) is increasingly being used in clinical practice for hemostasis testing and monitoring. It provides insights into the entire coagulation process including clot formation, strength, and breakdown. TEG finds applications in cardiothoracic surgery, liver transplantations, and assessment of bleeding risks. Market Dynamics: The market is driven by the rising prevalence of cardiovascular diseases and trauma cases worldwide. As per the World Health Organization, cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. TEG aids in effective management of blood coagulation in such high-risk patients. Moreover, technological advancemen